Healthcare -
Biotechnology - NASDAQ - CH
$ 8.01
-5.76 %
$ 54.7 K
Market Cap
-0.37
P/E
Price Target
Average
274.53%
Revenue Forecast
Estimate
108.60%
EBIT
Estimate
17.38%
Net Income
Estimate
--410.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Addex Therapeutics Ltd
Wall Street analysts predict an average 1-year price target for ADXN of $30 , with forecasts ranging from
a
low of
$30 to a high of $30 .
ADXN Lowest Price Target
Wall Street Target
30 USD
274.53%
ADXN Average Price Target
Wall Street Target
30 USD
274.53%
ADXN Highest Price Target
Wall Street Target
30 USD
274.53%
REVENUE FORECAST
Revenue Forecast Chart ADXN
EBIT FORECAST
EBIT Forecast Chart ADXN
NET INCOME FORECAST
Net Income Chart ADXN